Logo Logo

Publications by Peters, S.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 3.

Journal article

Peters, S.; Felip, E.; Dafni, U.; Belka, C.; Guckenberger, M.; Irigoyen, A.; Nadal, E.; Becker, A.; Vees, H.; Pless, M.; Martinez-Marti, A.; Tufman, A.; Lambrecht, M.; Andratschke, N.; Piguet, A. C.; Kassapian, M.; Roschitzki-Voser, H.; Rabaglio-Poretti, M.; Stahel, R. A.; Vansteenkiste, J.; De Ruysscher, D. (2019): Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial. In: Lung Cancer, Vol. 133: pp. 83-87

Karrasch, S.; Simon, M.; Herbig, B.; Langner, J.; Seeger, S.; Kronseder, A.; Peters, S.; Dietrich-Gümperlein, G.; Schierl, R.; Nowak, D.; Jörres, R. A. (2017): Health effects of laser printer emissions: a controlled exposure study. In: Indoor Air, Vol. 27, No. 4: pp. 753-765

Peters, S.; Stahel, R. A.; Kassapian, M.; Guckenberger, M.; Felip, E.; Langen, A. J. de; Huber, R. M.; Roschitzki-Voser, H.; Piguet, A.-C.; Ruysscher, D. de (2017): A feasibility trial evaluating the addition of nivolumab to standard first-line chemo-radiotherapy in locally advanced stage IIIA/B NSCLC: The ETOP 6-14 NICOLAS trial. In: Annals of Oncology, Vol. 28

This list was generated on Wed Aug 10 23:17:21 2022 CEST.